X4 Pharmaceuticals, Inc. (XFOR)
3.92
+0.04
(+1.03%)
USD |
NASDAQ |
Dec 12, 16:00
3.92
0.00 (0.00%)
After-Hours: 20:00
X4 Pharmaceuticals Cash from Investing (Quarterly): -28.67M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Pfizer Inc. | -2.43B |
| Altimmune, Inc. | -149.32M |
| Adverum Biotechnologies, Inc. | 1.858M |
| Hims & Hers Health, Inc. | -887.40M |
| Recursion Pharmaceuticals, Inc. | -2.549M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -27.82M |
| Cash from Financing (Quarterly) | 86.90M |
| Free Cash Flow | -106.13M |
| Free Cash Flow Per Share (Quarterly) | -0.6429 |
| Free Cash Flow to Equity (Quarterly) | -27.16M |
| Free Cash Flow to Firm (Quarterly) | -25.57M |
| Free Cash Flow Yield | -168.4% |